5 Amino 1MQ 10MG
$180.00
5 Amino 1MQ 10MG is a 10 milligram format of 5 amino 1 methylquinolinium, commonly referenced in research as a small molecule NNMT inhibitor. Researchers study it in the context of nicotinamide N methyltransferase activity, methylation related pathways, and cellular metabolism. Studies have examined NNMT inhibition in preclinical systems involving energy balance, adipocyte biology, and NAD related chemistry.
In Stock
5 Amino 1MQ 10MG is a 10 milligram format of 5 amino 1 methylquinolinium, a quaternary quinolinium small molecule widely discussed in the literature as an NNMT inhibitor. Researchers investigate 5 Amino 1MQ 10MG for its potential use as a tool compound in studies of nicotinamide N methyltransferase, including questions around methyl donor utilization and nicotinamide metabolite flux.
Work in cell and animal models has examined NNMT inhibition alongside metabolic phenotyping, adipose tissue signaling, and broader NAD pathway readouts, although findings can vary by model design and assay conditions. This compound is typically used in laboratory settings where controlled NNMT modulation is required for target engagement and pathway mapping.
- Specification: 10MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Trenbolone Acetate (Tra) 100mg/ml 10ml is a specified concentration and volume format of trenbolone acetate, an acetate ester of trenbolone and a synthetic anabolic androgenic steroid. Researchers may reference trenbolone acetate in studies involving androgen receptor signaling, steroid ester pharmacokinetics, and analytical method development. It is also encountered in forensic and anti doping research workflows focused on steroid identification.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Winstrol 100mg/ml 10ml refers to a 100 milligram per millilitre concentration supplied in a 10 millilitre format of stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers may reference stanozolol in studies involving androgen receptor signaling, anabolic steroid structure activity relationships, and metabolism profiling.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Trenbolone Enanthate (Tre) 100mg/ml 10ml is an oil based preparation of trenbolone enanthate, a synthetic anabolic androgenic steroid ester derived from 19 nor testosterone chemistry. Researchers may reference trenbolone esters in studies involving androgen receptor signaling, nitrogen balance models, and steroid pharmacokinetics. This format is commonly discussed in analytical and method development work where concentration and volume are specified.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
